Cash & equivalents increased 91.6%
Cash & equivalents changed +91.6% from the comparable as-filed period.
$21.4M→$40.9M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →LXRX financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory increased 611.9%
Inventory changed +611.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$168,000→$1.2M4 prior comparisons
Net income decreased 1077.1%
Net income changed -1077.1% from the comparable as-filed period.
$3.3M→-$31.8M2 prior comparisons
Operating income decreased 810.4%
Operating income changed -810.4% from the comparable as-filed period.
$3.7M→-$26.5M3 prior comparisons
Operating margin moved 384820 bp lower
Operating margin changed -384820 basis points from the comparable as-filed period.
12.94%→-3835.26%3 prior comparisons
Revenue decreased 97.6%
Revenue changed -97.6% from the comparable as-filed period.
$28.9M→$692,0003 prior comparisons
Research & development increased 10.8%
Research & development changed +10.8% from the comparable as-filed period.
$15.7M→$17.4M3 prior comparisons
Selling, general & administrative increased 4.3%
Selling, general & administrative changed +4.3% from the comparable as-filed period.
$9.4M→$9.8M3 prior comparisons
Stock-based compensation increased 3.1%
Stock-based compensation changed +3.1% from the comparable as-filed period.
$3.2M→$3.3M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.